Clinical Trial

Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy

Study acronym: CardioMET
Recruiting
View on ClinicalTrials.gov →
Summary
CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-21.
Trial Details
NCT Number NCT07375069
Lead Sponsor Federico II University
Conditions Type 2 Diabetes
Enrollment 3,000 participants
Start Date 2022-10-01
Primary Completion 2023-10-31 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-30